Paper - WANFANG MED ONLINE

You Position: Home > Paper

Stem cell based therapies for liver diseases: Current status and perspectives

( views:17, downloads:0 )

Author:: No author available

Journal Title:: World Chinese Journal of Digestology

Issue:: 1

DOI:: 10.11569/wcjd.v25.i1.17

Key Word:: 干细胞;肝脏疾病;治疗;Stem cells;Liver diseases;Therapy

Abstract：近年来干细胞研究越来越受到关注,干细胞可用于许多疾病,包括神经系统疾病、糖尿病、肾脏、肝脏疾病甚至癌症等的治疗.已有大量干细胞应用于肝病治疗的研究报道,尽管其中既充满了挑战也有许多困境与难题,但干细胞再生医学的临床应用仍将充满希望.

Reference

[1]林沪,张政,施明,等.人脐带间充质干细胞治疗肝硬化腹水患者的安全性[J].2012,(7).
[2]Abdelnasser A,Selim A,Fouad O,etc.Stem cell therapy improves the outcome of liver resection in cirrhotics.[J].2010,41(1).
[3]M, Wójcik,R, Bobowiec,F, Martelli.Effect of carotenoids on in vitro proliferation and differentiation of oval cells during neoplastic and non-neoplastic liver injuries in rats.[J].2008,59 Suppl 2.
[4]Dieter Birnbacher.Embryonic stem cell research and the argument of complicity[J].2009,18(1).
[5]Park, Yonsil,Chen, Yemiao,Ordovas, Laura,etc.Hepatic differentiation of human embryonic stem cells on microcarriers[J].2014,174.
[6]Mekala Subba Rao,Mitnala Sasikala,D Nageshwar Reddy.Thinking outside the liver: Induced pluripotent stem cells for hepatic applications[J].2013,(22).
[7]Faezeh, Shekari,Hossein, Baharvand,Ghasem Hosseini, Salekdeh.Organellar proteomics of embryonic stem cells.[J].2014,95.
[8]Shevela, E. Ya.,Starostina, N. M.,Pal'tsev, A. I.,etc.Efficiency of Cell Therapy in Liver Cirrhosis[J].2016,160(4).
[9]Brueckner, Sandra,Winkler, Sandra,Christ, Bruno.The Therapeutic Promise of Mesenchymal Stem Cells for Liver Restoration[J].2015,21(11).
[10]Shiqi Yang,Ayman Koteish,Huizhi Lin,etc.Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease[J].2004,39(2).
[11]Fox,I.J.,Duncan,S.A..Engineering liver tissue from induced pluripotent stem cells: A first step in generating new organs for transplantation?[J].2013,58(6).
[12]Gerbal-Chaloin,S.,Funakoshi,N.,Caillaud,A.,etc.Human induced pluripotent stem cells in hepatology: Beyond the proof of concept[J].2014,184(2).
[13]Chao, Jiang,Shuhai, Jia,Yong, Xu,etc.The application of multi-frequency fringe projection profilometry on the measurement of biological tissues.[J].2015,26.
[14]I L, Weissman.Stem cells: units of development, units of regeneration, and units in evolution.[J].2000,100(1).
[15]Khan, Zahida,Michalopoulos, George K..Liver Stem Cells: Experimental Findings and Implications for Human Liver Disease[J].2015,149(4).
[16]Bagher, Larijani,Ensieh Nasli, Esfahani,Peyvand, Amini,etc.Stem cell therapy in treatment of different diseases.[J].2012,50(2).
[17]Chao Sun,Jun-Jie Hu,Qin Pan,etc.Hepatic differentiation of rat induced pluripotent stem cells in vitro[J].2015,(39).
[18]Kenzaburo, Tani.Towards the safer clinical translation of human induced pluripotent stem cell-derived cells to regenerative medicine.[J].2015,2.
[19]Kopp, Janel L.,Sander, Maike,Grompe, Markus.Stem cells versus plasticity in liver and pancreas regeneration[J].2016,18(3).
[20]Evangelia Yannaki,Achilles Anagnostopoulos,Demetrios Kapetanos,etc.Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells[J].2006,34(11).
[21]Maguire, Greg.Therapeutics from Adult Stem Cells and the Hype Curve[J].2016,7(5).
[22]Shin Enosawa, D.D.S., Ph.D.,Reiko Horikawa, M.D., Ph.D.,Akiko Yamamoto, M.D.,etc.Hepatocyte Transplantation Using a Living Donor Reduced Graft in a Baby With Ornithine Transcarbamylase Deficiency: A Novel Source of Hepatocytes[J].2014,20(3).
[23]Kim, Gaeun,Eom, Young Woo,Baik, Soon Koo,etc.Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis[J].2015,30(10).
[24]Maciej, Tarnowski,Aleksander L, Sieron.Adult stem cells and their ability to differentiate.[J].2006,12.
[25]S Mobus,M Ott,J Hoepfner,etc.Improved hepatic differentiation strategies for human induced pluripotent stem cells.[J].2013,13(5).
[26]Playford R,Farzaneh F,Davies J,etc.Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor.[J].2006,24(7).
[27]Kern S,Eichler H,Stoeve J,etc.Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.[J].2006,24(5).
[28]Young Woo, Eom,Kwang Yong, Shim,Soon Koo, Baik.Mesenchymal stem cell therapy for liver fibrosis.[J].2015,30.
[29]S. Rutella,A. Gasbarrini,M.A. Zocco,etc.Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis[J].2007,39(9).
[30]Cao, Tong,Movahednia, Mohammad M.,Squier, Christopher A.,etc.Potential applications of keratinocytes derived from human embryonic stem cells[J].2016,11(1).
[31]Venkataramanan, R.,Gramignoli, R.,Soltys, K.A.,etc.New potential cell source for hepatocyte transplantation: Discarded livers from metabolic disease liver transplants[J].2013,11(1).
[32]Konstantin N, Yarygin,Alexei Y, Lupatov,Irina V, Kholodenko.Cell-based therapies of liver diseases: age-related challenges.[J].2015,10.
[33]S, Sell.Heterogeneity and plasticity of hepatocyte lineage cells.[J].2001,33(3).
[34]King,A.,Newsome,P.N..Bone marrow stem cell therapy for liver disease[J].2014,32(5).
[35]Sarah, Snykers,Joery, De Kock,Vanhaecke, Tamara,etc.Hepatic differentiation of mesenchymal stem cells: in vitro strategies.[J].2011,698.
[36]Cristina Margini,Ranka Vukotic,Lucia Brodosi,etc.Bone marrow derived stem cells for the treatment of end-stage liver disease[J].2014,(27).
[37]Mt, Abdel Aziz,Hm, Atta,Nk, Roshdy,etc.Amelioration of Murine Schistosoma mansoni Induced Liver Fibrosis by Mesenchymal Stem Cells.[J].2012,8(1).
[38]Miho Tama,Mami Aoki,Akihito Nishimura.In vitro recapitulation of the urea cycle using murine embryonic stem cell-derived in vitro liver model[J].2013,45(6).
[39]Goshi Shiota,Takahiro Kunisada,Kenji Oyama,etc.In vivo transfer of hepatocyte growth factor gene accelerates proliferation of hepatic oval cells in a 2-acetylaminofluorene/partial hepatectomy model in rats[J].2000,470(3).
[40]Mizumoto,H.,Matsumoto,K.,Hayashi,S.,etc.Evaluation of a hybrid artificial liver module based on a spheroid culture system of embryonic stem cell-derived hepatic cells[J].2012,21(2).
[41]Gaia S,Smedile A,Omede P,etc.Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease.[J].2006,45(1).
[42]Liu,T.,Zhang,S.,Xiang,D.,etc.Induction of hepatocyte-like cells from mouse embryonic stem cells by lentivirus-mediated constitutive expression of Foxa2/Hnf4a[J].2013,114(11).
[43]Khoury,M.,Chen,Q.,Chan,J.K.Y.,etc.Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells[J].2013,31(6).
[44]Philip, Roelandt,Jolien, Vanhove,Catherine, Verfaillie.Directed differentiation of pluripotent stem cells to functional hepatocytes.[J].2013,997.
[45]Khanna A,Katz RL,Estrov Z,etc.Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.[J].2002,346(10).